Avgjørelser
| Dato | Sak |
|---|---|
| 07.06.2019 | 19-027603TVI-OTIR/04 Fjällräven AB |
| 20.03.2019 | 18-172447TVI-OTIR/04 Apple Inc. |
| 13.03.2019 | 18-039917TVI-OTIR/04 Salgard AS |
| 08.01.2019 | 17-196713ASD-BORG/01 THEFACESHOP (komb.) |
| 08.11.2018 | 17-105565ASD-BORG/02 Nammo Schönebeck GmbH |
| 24.10.2018 | 17-136038TVI-OTIR/01 Neurim Pharmaceuticals (1991) Ltd |
| 09.10.2018 | 18-026405ASD-BORG/03 HUMANA AS |
| 04.04.2018 | 17-123376TVI-OTIR/08/17-123374TVI-OTIR/08 The Juice Plus+ Company, LLC |
| 01.03.2018 | 17-093213TVI-OTIR/06 Norcape |
| 03.01.2018 | 16-200820TVI-OTIR/06 Norax AS |
| 13.12.2017 | 16-091205TVI-OTIR/07 Merck Sharp & Dohme Corp |
| 08.12.2017 | 17-088009TVI-OTIR/02 Humana |
| 16.10.2017 | 17-003904TVI-OTIR/03 THEFACESHOP CO LTD |
| 29.09.2017 | 16-120029TVI-OTIR/01 Bayer Pharma AG |
| 11.04.2017 | 16-135037TVI-OTIR/07 Nammo Schönebeck GmbH |
| 06.04.2017 | E5/16 EFTA Vigeland |
| 13.02.2017 | 16-038564TVI-OTIR/03 Genentech Inc. |
| 01.11.2016 | HR-2016-2239-A ROUTE 66 |